SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

Shiba Inu is currently experiencing high levels of community discourse, with traders heavily debating its short-term price action and potential for a significant squeeze. Many participants are actively layering large buy orders to combat short positions, while others remain skeptical of the project's long-term utility and historical performance compared to newer meme coins.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum Inc. is experiencing heightened investor interest and volatility following news that the company secured a significant grant from the National Science Foundation, alongside broader optimism driven by executive actions establishing quantum computing as a national strategic priority. The community is actively debating the stock's future, weighing potential commercialization milestones against concerns regarding valuation, stock dilution, and market manipulation.

GraniteShares ETF Trust - GraniteShares 2x Long MU Daily ETF

GraniteShares 2x Long MU Daily ETF

MULL is trending as investors react to volatility in the memory sector, with the community actively debating the risks of leveraged decay versus the potential for rapid gains as Micron continues its aggressive AI-driven growth trajectory. Discussions center on strategic scaling and technical entry points, as traders navigate the product's high sensitivity to Micron's performance.

Ardelyx, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs. Its products include IBSRELA and XPHOZAH. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

Ardelyx is trending as investors monitor the final legal outcome regarding Medicare bundling for Xphozah, while actively discussing the potential for a rerating once the company achieves sustained profitability. The community remains focused on robust Ibsrela sales momentum, upcoming clinical trial readouts, and speculation regarding a potential buyout.

Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.

Immix Biopharma Inc

Immix Biopharma is trending as investors focus on the company's progress with its NXC-201 CAR-T therapy for AL amyloidosis, specifically anticipating upcoming trial data and a potential BLA submission. The community is actively discussing the company's strong institutional backing and the strategic implications of new leadership hires as they navigate the path toward clinical milestones.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is seeing intense community debate over its long-term commercial strategy following its recent acquisition of Melinta Therapeutics and the expiration of TDAPA reimbursement. Investors are actively scrutinizing management's execution of DefenCath adoption, the potential for legislative support via K-CAPA, and the impact of upcoming quarterly earnings on share price stability.

TELUS Corp. is a telecommunications company, which engages in the provision of telecommunication services and products primarily for wireless and wireline voice and data. It operates through TELUS Technology Solutions (TTech) and Digitally-led Customer Experiences–TELUS International (DLCX) segments. The TTech segment includes network revenues and equipment sales arising from mobile technologies, data revenues, healthcare software and technology solutions, voice and other telecommunications services revenues, and equipment sales. The DLCX segment is composed of digital customer experience and digital-enablement transformation solutions, including artificial intelligence and content management solutions, provided by TELUS International. The company was founded on October 4, 1990 and is headquartered in Vancouver, Canada.

Telus Corp.

Telus is capturing investor attention as the community actively debates whether the company's dividend remains sustainable amid heavy infrastructure investments and a shifting telecom landscape. While some investors see a long-term value opportunity in its diversified growth strategy and AI expansion, others express frustration over recent stock performance and lingering concerns regarding debt levels and competitive pressures.

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Medtronic Plc

Medtronic is capturing market attention as the company navigates strategic restructuring and board appointments following a significant stake from Elliott Investment Management, while simultaneously leveraging strong procedure demand and new product pipeline momentum. Investors are actively debating the company's long-term growth potential and dividend stability as it balances ongoing innovation in medical devices with broader sector-wide rotation trends.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

The Grayscale Bitcoin Mini Trust is capturing investor attention as the broader crypto market navigates high-stakes regulatory developments, including the Digital Asset Market CLARITY Act. Community discourse remains heavily focused on institutional inflows and Bitcoin's potential to serve as a macro hedge, despite ongoing debates regarding price volatility and the long-term impact of ETF flows.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is trending as the community remains deeply divided between long-term holders accumulating during the price dip and vocal critics labeling the project a scam with failing utility. Discussion is currently focused on the lack of major roadmap updates, the potential impact of new ecosystem projects, and intense debate over whether current price levels represent a generational buying opportunity or a terminal decline.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

10 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session

Gainers

CarParts.com (NASDAQ:PRTS) stock moved upwards by 7.6% to $6.9 during Tuesday's pre-market session. The market value of their outstanding shares is at $51.9 million.
Lovesac (NASDAQ:LOVE) shares increasedread more...

Lovesac Q1 Earnings Call Highlights Product Push, Outlook

LOVE keeps its fiscal 2027 outlook intact as management has highlighted product launches, digital marketing gains and supply-chain changes after mixed first-quarter results.

Here's What Key Metrics Tell Us About Lovesac (LOVE) Q1 Earnings

Although the revenue and EPS for Lovesac (LOVE) give a sense of how its business performed in the quarter ended April 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Lovesac (LOVE) Reports Q1 Loss, Beats Revenue Estimates

Lovesac (LOVE) delivered earnings and revenue surprises of +26.21% and +0.81%, respectively, for the quarter ended April 2026. Do the numbers hold clues to what lies ahead for the stock?

Lovesac Posts Wider Loss In Q1

(RTTNews) - The Lovesac Company (LOVE) posted a net loss of $11.1 million in the first quarter of fiscal 2027 or $0.76 per share compared to a loss of $10.8 million or $0.73 per share in the prior year period. During the first quarter of fiscal 2027, the company recorded an incom...

Lovesac Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

The Lovesac Company (NASDAQ: LOVE) will release Q1 earnings on June 11. Analysts predict a loss of 90 cents/share, higher than last year. Stock closed at $16.48 on Wed.read more...

Countdown to Lovesac (LOVE) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS

Evaluate the expected performance of Lovesac (LOVE) for the quarter ended April 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Williams-Sonoma (WSM) Tops Q1 Earnings and Revenue Estimates

Williams-Sonoma (WSM) delivered earnings and revenue surprises of +7.22% and +0.05%, respectively, for the quarter ended April 2026. Do the numbers hold clues to what lies ahead for the stock?

The Lovesac Company (NASDAQ:LOVE) Given Consensus Rating of "Moderate Buy" by Analysts

Shares of The Lovesac Company (NASDAQ:LOVE - Get Free Report) have received an average recommendation of 'Moderate Buy' from the five analysts that are covering the company, MarketBeat.com reports...

Insider Buying: Lovesac (NASDAQ:LOVE) CEO Buys 1,477 Shares of Stock

The Lovesac Company (NASDAQ:LOVE - Get Free Report) CEO Shawn David Nelson acquired 1,477 shares of the firm's stock in a transaction that occurred on Thursday, April 16th. The stock was purchased at...

The Lovesac Co. is a technology driven, omni-channel company. It designs, manufactures, and sells furniture comprised of modular couches called sactionals and foam beanbag chairs called sacs. Its products include sactionals, sacs, and accessories. The company was founded by Shawn David Nelson in 1995 and is headquartered in Stamford, CT.

Lovesac Company

Lovesac Pops On Strong Q4 Results: Retail Investors Turn Extremely Bullish

Equity

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is headed towards another losing week. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$16.34
Prev Close	$16.37
Open	$16.52
Dividend Yield	0.00%
50-Day Moving Average	$16.26
Beta	1.50
Avg. Volume	230,810.64
PE Ratio	63.88

52-Week High	$20.88
52-Week Low	$10.33
Market Capitalization	$239.19M
EPS (Annual)	$0.2766
Price to Book	1.16
Revenue Per Employee	$366,902.63

Feed

News

Sentiment

Earnings

Fundamentals

Info

LOVELovesac Company

Latest LOVE News